ORGARAN Side Effects

7026566-3 | Alanine Aminotransferase Increased, Anaphylactoid Shock, Aspartate Aminotransferase Increased, Cardiogenic Shock, Pancreatitis
on Sep 23, 2010 Female patient from FRANCE , 32 years of age, was treated with Orgaran (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anaphylactoid shock, aspartate aminotransferase increased, cardiogenic shock, pancreatitis. Orgaran dosage: Sc. During the same period patient was treated with FUROSEMIDE (Iv) (View Furosemide Review and Furosemide Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), DIPRIVAN (Iv) (View Diprivan Review and Diprivan Label ), AUGMENTIN '125' (Iv) (View Augmentin '125' Review and Augmentin '125' Label ), CLAFORAN (Iv) (View Claforan Review and Claforan Label ), PANTOPRAZOLE (Iv) (View Pantoprazole Review and Pantoprazole Label ), FENTANYL 100 (Iv) (View Fentanyl-100 Review and Fentanyl-100 Label ), MIDAZOLAM HCL (Iv) (View Midazolam Hcl Review and Midazolam Hcl Label ). Patient was hospitalized.

7021615-0 | Automatism, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Cytolytic Hepatitis, Fibrin D Dimer Increased, Haemorrhagic Stroke, Idiopathic Thrombocytopenic Purpura, Loss Of Consciousness
Patient was taking Orgaran (View Usage). Patient had the following side effects: automatism, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, cytolytic hepatitis, fibrin d dimer increased, haemorrhagic stroke, idiopathic thrombocytopenic purpura, loss of consciousness on Sep 23, 2010 from FRANCE Additional patient health information: Male patient , 70 years of age, was diagnosed with platelet count decreased and. Orgaran dosage: Iv. During the same period patient was treated with TEGELINE (View Tegeline Review and Tegeline Label ), CORTICOID (View Corticoid Review and Corticoid Label ). Patient was hospitalized.

7007531-9 | Arterial Thrombosis, Cerebral Haematoma, Cross Sensitivity Reaction, Hemiplegia, Pulmonary Embolism, Somnolence, Thrombocytopenia
Adverse event was reported on Sep 08, 2010 by a Male patient taking Orgaran (View Usage) (Dosage: 750 Iu Qd Sc) . Location: FRANCE , 34 years of age, After Orgaran was administered, patient had the following side effects: arterial thrombosis, cerebral haematoma, cross sensitivity reaction, hemiplegia, pulmonary embolism (What is pulmonary embolism?), somnolence, thrombocytopenia. During the same period patient was treated with LOVENOX (60 Mg Qd Sc) (View Lovenox Review and Lovenox Label ), VASTEN (View Vasten Review and Vasten Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ). Patient was hospitalized.

7007146-2 | Pemphigoid, Urticaria
on Sep 06, 2010 Male patient from FRANCE , 78 years of age, was diagnosed with thrombosis prophylaxis and was treated with Orgaran (View Usage). Patient experienced the following unwanted or unexpected effects: pemphigoid, urticaria. Orgaran dosage: 3750 Iu;biw;iv. During the same period patient was treated with BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), LASIX (View Lasix Review and Lasix Label ), TAHOR (View Tahor Review and Tahor Label ), RENAGEL (View Renagel Review and Renagel Label ), GABAPENTINE (View Gabapentine Review and Gabapentine Label ).


7006479-3 |
on Sep 03, 2010 Female patient from JAPAN , 33 years of age, was treated with Orgaran (View Usage). . Orgaran dosage: Iv. During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ), BAFFERIN (View Bafferin Review and Bafferin Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ).

6964096-5 | Congenital Uterine Anomaly
Patient was taking Orgaran (View Usage). After Orgaran was administered, patient had the following side effects: congenital uterine anomaly on Aug 25, 2010 from JAPAN Additional patient health information: Female patient , 33 years of age, . Orgaran dosage: Iv. During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ), BAFERIN (ASPIRIN) (View Baferin (aspirin) Review and Baferin (aspirin) Label ), HEPARIN SODIUM (View Heparin Sodium Review and Heparin Sodium Label ), CAPROCIN (View Caprocin Review and Caprocin Label ).

6800186-5 | Abdominal Distension, Anaemia, Aortic Dissection, Arrhythmia, Condition Aggravated, Diarrhoea, Diverticulum Intestinal, Gastrointestinal Disorder
Adverse event was reported on Jun 10, 2010 by a Male patient taking Orgaran (View Usage) (Dosage: ; Iv) was diagnosed with heparin-induced thrombocytopenia and. Location: FRANCE , 77 years of age, Patient experienced the following unwanted or unexpected effects: abdominal distension, anaemia, aortic dissection, arrhythmia (What is arrhythmia?), condition aggravated, diarrhoea, diverticulum intestinal, gastrointestinal disorder. Patient was hospitalized.

6791405-2 | Arterial Thrombosis Limb, Cerebrovascular Accident, Fall, Leukocytosis, Mydriasis, Nystagmus, Thrombocytopenia, Thrombophlebitis Superficial
on Jun 15, 2010 Female patient from FRANCE , 83 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Orgaran (View Usage). Patient had the following side effects: arterial thrombosis limb, cerebrovascular accident, fall (What is fall?), leukocytosis, mydriasis, nystagmus, thrombocytopenia, thrombophlebitis superficial. Orgaran dosage: Sc:iv. During the same period patient was treated with CALCIPARINE (Sc) (View Calciparine Review and Calciparine Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6769335-1 | Disseminated Intravascular Coagulation, Heparin-induced Thrombocytopenia, Infarction, Thrombosis, Vascular Graft Occlusion
on May 31, 2010 Female patient from FRANCE , 70 years of age, was diagnosed with disseminated intravascular coagulation, thrombocytopenia, vascular graft and was treated with Orgaran (View Usage). After Orgaran was administered, patient had the following side effects: disseminated intravascular coagulation, heparin-induced thrombocytopenia, infarction, thrombosis, vascular graft occlusion. Orgaran dosage: . Patient was hospitalized.

6754985-9 | Acidosis, Dialysis, Hyperthermia, Lung Infection, Phlebitis, Platelet Count Decreased, Renal Failure, Respiratory Failure
Patient was taking Orgaran (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, dialysis (What is dialysis?), hyperthermia, lung infection, phlebitis, platelet count decreased, renal failure, respiratory failure on May 28, 2010 from FRANCE Additional patient health information: Male patient , 80 years of age, was diagnosed with heparin-induced thrombocytopenia, arteriogram coronary and. Orgaran dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

6742332-8 | Heparin-induced Thrombocytopenia, Leg Amputation
Adverse event was reported on May 19, 2010 by a Female patient taking Orgaran (View Usage) (Dosage: 750 Iu; Tid; Sc) was diagnosed with thrombocytopenia, pulmonary embolism (What is pulmonary embolism?) and. Location: FRANCE , 74 years of age, Patient had the following side effects: heparin-induced thrombocytopenia, leg amputation. During the same period patient was treated with HEPARIN SODIUM (; Iv) (View Heparin Sodium Review and Heparin Sodium Label ), SECTRAL (View Sectral Review and Sectral Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6736459-4 | Heparin-induced Thrombocytopenia, Ischaemic Stroke
on May 12, 2010 Male patient from FRANCE , 69 years of age, was treated with Orgaran (View Usage). After Orgaran was administered, patient had the following side effects: heparin-induced thrombocytopenia, ischaemic stroke. Orgaran dosage: 750 Iu;bid;sc. During the same period patient was treated with HEPARIN SODIUM (Sc) (View Heparin Sodium Review and Heparin Sodium Label ).

6717371-3 | Heparin-induced Thrombocytopenia
on Apr 28, 2010 Male patient from FRANCE , 69 years of age, was treated with Orgaran (View Usage). Patient experienced the following unwanted or unexpected effects: heparin-induced thrombocytopenia. Orgaran dosage: 750 Iu;bid;sc. During the same period patient was treated with HEPARIN SODIUM (Sc) (View Heparin Sodium Review and Heparin Sodium Label ).

6710500-7 | Atrial Fibrillation, Pericardial Effusion, Thrombocytopenia
Patient was taking Orgaran (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), pericardial effusion, thrombocytopenia on Apr 22, 2010 from FRANCE Additional patient health information: Male patient , 70 years of age, was diagnosed with thrombosis prophylaxis, thrombocytopenia and. Orgaran dosage: 750 Iu;bid;sc. During the same period patient was treated with ARIXTRA (1 Df;qd;sc) (View Arixtra Review and Arixtra Label ), LOVENOX (View Lovenox Review and Lovenox Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), CRESTOR (View Crestor Review and Crestor Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6673843-1 | Intestinal Haemorrhage, Intestinal Perforation, Peritonitis, Pneumonia
Adverse event was reported on Mar 31, 2010 by a Female patient taking Orgaran (View Usage) (Dosage: 1000 Df; Bid; Sc) was diagnosed with heparin-induced thrombocytopenia, renal failure and. Location: AUSTRALIA , 67 years of age, After Orgaran was administered, patient had the following side effects: intestinal haemorrhage, intestinal perforation, peritonitis, pneumonia (What is pneumonia?). During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), AMIODARON /00133101/ (View Amiodaron /00133101/ Review and Amiodaron /00133101/ Label ). Patient was hospitalized.

6667001-4 | Deep Vein Thrombosis, Heparin-induced Thrombocytopenia, Leg Amputation, Popliteal Pulse Abnormal, Thrombophlebitis Superficial
on Mar 25, 2010 Female patient from FRANCE , 74 years of age, was diagnosed with thrombocytopenia, pulmonary embolism (What is pulmonary embolism?) and was treated with Orgaran (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), heparin-induced thrombocytopenia, leg amputation, popliteal pulse abnormal, thrombophlebitis superficial. Orgaran dosage: 750 Iu; Tid; Sc. During the same period patient was treated with SECTRAL (View Sectral Review and Sectral Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6653980-8 | Peripheral Embolism
on Mar 16, 2010 Female patient from GERMANY , 72 years of age, weighting 224.9 lb, was diagnosed with thrombosis prophylaxis and was treated with Orgaran (View Usage). Patient had the following side effects: peripheral embolism. Orgaran dosage: 750 Iu; Bid; Sc. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), LOW MOLECULAR HEPARINE (LOW MOLECULAR WEIGHT HEPARIN) (View Low-molecular Heparine (low Molecular Weight Heparin) Review and Low-molecular Heparine (low Molecular Weight Heparin) Label ), ARGATRA (ARGATROBAN) (View Argatra (argatroban) Review and Argatra (argatroban) Label ). Patient was hospitalized.

6652474-3 | Coronary Artery Bypass, Intestinal Perforation, Peritonitis, Platelet Aggregation, Pneumonia, Post Procedural Complication, Renal Failure
Patient was taking Orgaran (View Usage). After Orgaran was administered, patient had the following side effects: coronary artery bypass (What is coronary artery bypass?), intestinal perforation, peritonitis, platelet aggregation, pneumonia (What is pneumonia?), post procedural complication, renal failure on Mar 16, 2010 from AUSTRALIA Additional patient health information: Female patient , 67 years of age, . Orgaran dosage: ;bid;unk. Patient was hospitalized.

6642699-5 | Anaphylactic Shock, Erythema, Oxygen Saturation Decreased, Tachycardia
Adverse event was reported on Mar 08, 2010 by a Male patient taking Orgaran (View Usage) (Dosage: 3000 Iu;once;iv) was diagnosed with thrombosis prophylaxis and. Location: FRANCE , 51 years of age, Patient experienced the following unwanted or unexpected effects: anaphylactic shock, erythema, oxygen saturation decreased, tachycardia. During the same period patient was treated with DIPRIVAN (CON.) (View Diprivan (con.) Review and Diprivan (con.) Label ), ETOMIDATE (CON.) (View Etomidate (con.) Review and Etomidate (con.) Label ), SUFENTA (CON.) (View Sufenta (con.) Review and Sufenta (con.) Label ), KEFANDOL (CON.) (View Kefandol (con.) Review and Kefandol (con.) Label ), DESFLURANE (CON.) (View Desflurane (con.) Review and Desflurane (con.) Label ), NIMBEX (CON.) (View Nimbex (con.) Review and Nimbex (con.) Label ). Patient was hospitalized.

6636203-5 | Antibody Test Positive, Arterial Thrombosis Limb, C-reactive Protein Increased, Cerebrovascular Accident, Chronic Myelomonocytic Leukaemia, Cyanosis, Deep Vein Thrombosis, Extensor Plantar Response, Fall
on Jan 25, 2010 Female patient from FRANCE , 83 years of age, was diagnosed with heparin-induced thrombocytopenia, thrombosis prophylaxis and was treated with Orgaran (View Usage). Patient had the following side effects: antibody test positive, arterial thrombosis limb, c-reactive protein increased, cerebrovascular accident, chronic myelomonocytic leukaemia, cyanosis, deep vein thrombosis (What is deep vein thrombosis?), extensor plantar response, fall (What is fall?). Orgaran dosage: Sc;iv. During the same period patient was treated with CALCIPARINE (Sc) (View Calciparine Review and Calciparine Label ), RISPERDAL (CON.) (View Risperdal (con.) Review and Risperdal (con.) Label ), PARACETAMOL (CON.) (View Paracetamol (con.) Review and Paracetamol (con.) Label ).

6619257-1 | Embolism
on Feb 23, 2010 Female patient from GERMANY , 72 years of age, weighting 224.9 lb, was diagnosed with thrombosis prophylaxis and was treated with Orgaran (View Usage). After Orgaran was administered, patient had the following side effects: embolism. Orgaran dosage: 750 Iu; Bid; Sc. During the same period patient was treated with ............... (View ............... Review and ............... Label ), HEPARIN (View Heparin Review and Heparin Label ), LOW MOLECULAR HEPARINE (LOW MOLECULAR WEIGHT HEPARIN) (View Low-molecular Heparine (low Molecular Weight Heparin) Review and Low-molecular Heparine (low Molecular Weight Heparin) Label ), ARGATRA (ARGATROBAN) (View Argatra (argatroban) Review and Argatra (argatroban) Label ). Patient was hospitalized.

6599413-1 | Acute Pulmonary Oedema, Confusional State, Diabetes Mellitus, Epistaxis, Haemoglobin Decreased, Haemorrhagic Anaemia, Incorrect Dose Administered, Infection, International Normalised Ratio Increased
Patient was taking Orgaran (View Usage). Patient experienced the following unwanted or unexpected effects: acute pulmonary oedema, confusional state, diabetes mellitus, epistaxis, haemoglobin decreased, haemorrhagic anaemia, incorrect dose administered, infection (What is infection?), international normalised ratio increased on Feb 05, 2010 from FRANCE Additional patient health information: Male patient , 82 years of age, was diagnosed with cardiac valve prosthesis user and. Orgaran dosage: 2000 Iu; Bid; Sc. During the same period patient was treated with CALCIIPARINE (HEPARIN CALCIUM) (Qd; Sc, Qd; Sc) (View Calciiparine (heparin Calcium) Review and Calciiparine (heparin Calcium) Label ), COUMADIN (Po; 1 Mg; Qd; 2 Mg; Qd) (View Coumadin Review and Coumadin Label ).

6597770-3 | Injection Site Reaction
Adverse event was reported on Feb 16, 2010 by a Female patient taking Orgaran (View Usage) (Dosage: Sc) . Location: FRANCE , 53 years of age, Patient had the following side effects: injection site reaction. During the same period patient was treated with LOVENOX (0.4 Ml; Qd; Sc) (View Lovenox Review and Lovenox Label ). Patient was hospitalized.

6592856-1 | Cutaneous Lupus Erythematosus, Localised Infection, Stevens-johnson Syndrome
on Jan 29, 2010 Male patient from FRANCE , 54 years of age, weighting 202.8 lb, was diagnosed with arrhythmia (What is arrhythmia?), atrial fibrillation (What is atrial fibrillation?), heparin-induced thrombocytopenia and was treated with Orgaran (View Usage). After Orgaran was administered, patient had the following side effects: cutaneous lupus erythematosus, localised infection, stevens-johnson syndrome. Orgaran dosage: 250 Iu;qh;iv. During the same period patient was treated with DOBUTAMINE (View Dobutamine Review and Dobutamine Label ), LASILIX (View Lasilix Review and Lasilix Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ALDACTONE (View Aldactone Review and Aldactone Label ). Patient was hospitalized.

6574350-7 | Arterial Thrombosis Limb, Cerebrovascular Accident, Deep Vein Thrombosis, Extensor Plantar Response, Fall, Leukaemia Monocytic, Mydriasis, Myoclonus
on Jan 25, 2010 Female patient from FRANCE , 83 years of age, was diagnosed with heparin-induced thrombocytopenia, thrombosis prophylaxis and was treated with Orgaran (View Usage). Patient experienced the following unwanted or unexpected effects: arterial thrombosis limb, cerebrovascular accident, deep vein thrombosis (What is deep vein thrombosis?), extensor plantar response, fall (What is fall?), leukaemia monocytic, mydriasis, myoclonus. Orgaran dosage: Sc; Iv. During the same period patient was treated with CALCIPARINE (Sc) (View Calciparine Review and Calciparine Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

6551321-8 | Embolism, Underdose
Patient was taking Orgaran (View Usage). Patient had the following side effects: embolism, underdose on Jan 12, 2010 from GERMANY Additional patient health information: Female patient , 72 years of age, weighting 224.9 lb, was diagnosed with thrombosis prophylaxis and. Orgaran dosage: 750 Iu; Bid;sc.

6529039-7 | Condition Aggravated, Deep Vein Thrombosis, Heparin-induced Thrombocytopenia, Multi-organ Failure, Peripheral Ischaemia
Adverse event was reported on Dec 29, 2009 by a Female patient taking Orgaran (View Usage) (Dosage: Once) . Location: FRANCE , 86 years of age, After Orgaran was administered, patient had the following side effects: condition aggravated, deep vein thrombosis (What is deep vein thrombosis?), heparin-induced thrombocytopenia, multi-organ failure, peripheral ischaemia. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ACEBUTOLOL (CON.) (View Acebutolol (con.) Review and Acebutolol (con.) Label ), COZAAR (CON.) (View Cozaar (con.) Review and Cozaar (con.) Label ), BURINEX (CON.) (View Burinex (con.) Review and Burinex (con.) Label ), DIFFU K (CON.) (View Diffu-k (con.) Review and Diffu-k (con.) Label ), FENOFIBRATE (CON.) (View Fenofibrate (con.) Review and Fenofibrate (con.) Label ). Patient was hospitalized.

6485136-6 | Decubitus Ulcer, Dermatitis Bullous, Skin Necrosis, Stevens-johnson Syndrome, Toxic Skin Eruption
on Nov 20, 2009 Male patient from FRANCE , 54 years of age, weighting 202.8 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?), heparin-induced thrombocytopenia and was treated with Orgaran (View Usage). Patient experienced the following unwanted or unexpected effects: decubitus ulcer, dermatitis bullous, skin necrosis, stevens-johnson syndrome, toxic skin eruption. Orgaran dosage: 250 Iu;qh; Iv. During the same period patient was treated with DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ), LASILIX (View Lasilix Review and Lasilix Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ALDACTONE (View Aldactone Review and Aldactone Label ). Patient was hospitalized.

6452725-4 | Thrombocytopenia
on Nov 05, 2009 Male patient from FRANCE , 73 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Orgaran (View Usage). Patient had the following side effects: thrombocytopenia. Orgaran dosage: . During the same period patient was treated with AUGMENTIN (View Augmentin Review and Augmentin Label ), TAZOCILLINE (PIP/TAZO) (View Tazocilline (pip/tazo) Review and Tazocilline (pip/tazo) Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), PIPERACILLIN SODIUM (View Piperacillin Sodium Review and Piperacillin Sodium Label ). Patient was hospitalized.

6452296-2 | Skin Necrosis, Toxic Skin Eruption
Patient was taking Orgaran (View Usage). After Orgaran was administered, patient had the following side effects: skin necrosis, toxic skin eruption on Nov 09, 2009 from FRANCE Additional patient health information: Male patient , 50 years of age, was diagnosed with heparin-induced thrombocytopenia and. Orgaran dosage: 250 Iu;qh;iv. During the same period patient was treated with DOBUTAMINE (CON.) (View Dobutamine (con.) Review and Dobutamine (con.) Label ), LASILIX (CON.) (View Lasilix (con.) Review and Lasilix (con.) Label ), DIGOXINE (CON.) (View Digoxine (con.) Review and Digoxine (con.) Label ). Patient was hospitalized.

6392191-0 | Retroplacental Haematoma, Threatened Labour
Adverse event was reported on Sep 24, 2009 by a Female patient taking Orgaran (View Usage) (Dosage: Iv) . Location: JAPAN , 36 years of age, Patient experienced the following unwanted or unexpected effects: retroplacental haematoma, threatened labour. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), POLYGAM S/D (View Polygam S/d Review and Polygam S/d Label ). Patient was hospitalized.

6384675-6 | Toxic Skin Eruption
on Sep 18, 2009 Female patient from FRANCE , 86 years of age, was diagnosed with thrombocytopenia and was treated with Orgaran (View Usage). Patient had the following side effects: toxic skin eruption. Orgaran dosage: 750 Iu;bid;sc. During the same period patient was treated with OXYCONTIN (View Oxycontin Review and Oxycontin Label ), TRIATEC (View Triatec Review and Triatec Label ), ESIDRIX (View Esidrix Review and Esidrix Label ), AERIUS (View Aerius Review and Aerius Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), ATARAX (View Atarax Review and Atarax Label ), INSULIN NOVOMIX (View Insulin Novomix Review and Insulin Novomix Label ), INIPOMP (View Inipomp Review and Inipomp Label ). Patient was hospitalized.

6359361-9 | Cerebral Haematoma, Coma, Intracranial Pressure Increased
on Sep 09, 2009 Female patient from FRANCE , 58 years of age, was treated with Orgaran (View Usage). After Orgaran was administered, patient had the following side effects: cerebral haematoma, coma, intracranial pressure increased. Orgaran dosage: 3000 Iu; Tiw; Sc.

6211828-X | Platelet Count Decreased, Pyrexia
Patient was taking Orgaran (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased, pyrexia on May 14, 2009 from JAPAN Additional patient health information: Male patient , 56 years of age, was diagnosed with disseminated intravascular coagulation and. Orgaran dosage: 2500 Iu Intravenous Drip 3 Weeks 3 Days 2500 Intravenous Drip 1 Week 1 Day. During the same period patient was treated with MEROPEN (View Meropen Review and Meropen Label ), PROPOFOL (View Propofol Review and Propofol Label ), ASPARA POTASSIUM (View Aspara Potassium Review and Aspara Potassium Label ), FLUMAZENIL (View Flumazenil Review and Flumazenil Label ), ELASPOL (View Elaspol Review and Elaspol Label ), SERENACE (View Serenace Review and Serenace Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ). Patient was hospitalized.

4886907-X | Deep Vein Thrombosis, Haemodialysis, Heparin-induced Thrombocytopenia, Phlebitis, Pulmonary Haemorrhage, Renal Failure Acute, Shock
Adverse event was reported on Jan 01, 2005 by a Male patient taking Orgaran (View Usage) (Dosage: 2250 Anti_xa Intravenous (nos)) was diagnosed with prophylaxis and. Location: FRANCE , 83 years of age, Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), haemodialysis, heparin-induced thrombocytopenia, phlebitis, pulmonary haemorrhage, renal failure acute, shock. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), LEPIRUDIN (View Lepirudin Review and Lepirudin Label ).